Long-term considerations If split dosing works for you in the short term, what happens over months and years of continued use
eligible Medicare patients can access FDA-approved GLP-1 medications for $50/month through the CMS Medicare GLP-1 Bridge Program - a different pathway worth evaluating before enrolling in a cash-pay compounded program FDA adverse event data (as of May 21, 2026): FDA had received more than 1,700 adverse events associated with compounded semaglutide and tirzepatide combined - a safety signal not specific to Omzo but material context for any compounded GLP-1 enrollment decision
Weight loss with semaglutide is a gradual process and works best when combined with healthy lifestyle changes and ongoing medical support
You've essentially bent the key
Essentially, investigations for diagnosis are variable which was reflected across the literature gathered
The program cost includes peptide vial(s), supplies, provider guidance, instructions, and follow-up support when prescribed